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Based on a massive transcription factor location analysis within a single cell type, in this issue
Yan et al. find that the greatmajority of occupancies occur within dense clusters of up to 100 factors
that almost invariably contain cohesins. Retention of cohesins at cluster sites during mitosis raises
the possibility that they contribute to transcriptional memory during the cell cycle.Transcriptional regulators function com-
binatorially to control eukaryotic gene
expression at the right place, time, and
level. Transcription-factor-binding sites
cluster at regulatory elements that can
be promoter proximal but also be located
up to hundreds of kilobases away. Juxta-
position of cis elements might confer
synergy in binding to chromatin and in
the recruitment of coregulatory mole-
cules. Most known enhancer elements
bind tissue- and gene-specific factors
in combination with widely expressed
DNA-binding proteins.
In this issue of Cell, Yan et al. (2013)
take the analysis of transcription factor
occupancy at enhancers to a new level
by analyzing in a single cell type over
100 transcription factors by ChIP-seq
(chromatin immunoprecipitation followed
by second-generation sequencing),
including DNA-binding and nonbinding
coregulators. The number of factors
examined exceeds the total number of
transcription factors published previouslyby the ENCODE project (Gerstein et al.,
2012).
Transcription-factor-binding sites vary
in number from 300 to 45,000 but,
notably, occur in clusters of up to 100
transcription factors confined on average
to less than 2 kb in size. Cluster sizes
correlate with gene expression and
enhancer chromatin marks as one might
expect but, surprisingly, clusters include
factors that share few functional GO
annotations. Although clusters of tran-
scription factor binding have been
observed in multiple recent studies (so-
called high occupancy or HOT regions;
MacArthur et al., 2009; Yip et al., 2012),
the sheer number of transcription factors
examined in the present study reveals a
far greater degree of transcription factor
clustering than previously observed.
Yan et al. point out that a substantial
number of factors must be examined to
observe the clusters, and one would
expect that further mapping of additional
factors will show how commonly clusterscapture the majority of binding. The
authors also find that the vast majority of
clusters containing at least 20 transcrip-
tion factors are marked by the presence
of cohesin. Previous experiments in
Drosophila and mice also found that
nearly all cis-regulatory modules are
bound by cohesin and/or its loading
factors (Kagey et al., 2010; Schaaf et al.,
2013), but recent studies of co-occu-
pancy of large numbers of factors in
human cells do not find cohesin as part
of almost all clusters (Gerstein et al.,
2012; Yip et al., 2012). Again, furthermap-
ping of the locations of larger numbers
of factors in diverse species and cell
types should resolve this apparent
discrepancy. Importantly, each study
defined clusters in a distinct way and
employed different methods of analysis.
Future work should reveal which con-
clusions are robust to the different meth-
odological approaches.
Cohesins in combination with mediator
and/or CTCF are thought to aid in forming
Figure 1. Transcription Factor Clusters and
the Cell Cycle
Most transcription factors dissociate from chro-
matin during mitosis. In contrast, cohesin is
retained on mitotic chromosomes at sites of
transcription factor clustering. In this speculative
model, cohesin maintains an open chromatin
configuration to facilitate reloading of transcription
factors during entry into the G1 phase of the cell
cycle.looped contacts between enhancers and
target promoters (Hadjur et al., 2009; Ka-
gey et al., 2010). Mechanistically, it has
been hypothesized that cohesins encircle
juxtaposed genomic DNA in a manner
similar to cohesin’s function in sister
chromatid cohesion (Dorsett and Mer-
kenschlager, 2013). An unexpected new
finding of the present study is that cohe-
sins remain associated with transcription
factor cluster sites during mitosis. The
majority of nuclear factors vacate their
binding sites during mitosis, leading to
global transcriptional shut down. How-
ever, some transcription factors as well
as select histone marks are retained on
mitotic chromatin, leading to the specu-
lation that they perform a memory or
‘‘bookmarking’’ function to ensure the
timely and precise reactivation of tran-
scription in the next G1 phase of the
cell cycle (Kadauke and Blobel, 2013).Remarkably, cohesins are retained at
cluster sites even if DNA-binding proteins
are displaced from the clusters. More-
over, cohesin retention is independent of
CTCF, a DNA-binding protein found at
insulators and some boundaries of chro-
matin domains and capable of recruiting
cohesins (Dorsett and Merkenschlager,
2013). Based on this observation the
authors speculate that cohesin retention
at cluster sites during mitosis might facili-
tate reloading of transcription factors
upon mitotic exit. If so, cohesins might
establish and maintain DNA accessibility
(Figure 1). In support of this idea, the
authors provide data showing that
depletion of cohesins is associated with
diminished DNase sensitivity, and alter-
ations in both transcription factor occu-
pancies and gene expression. Given the
ostensibly global role of cohesins in the
regulation of transcription, it is expected
that some of the consequences of cohe-
sin loss are indirect. This might explain
why the number of up- and downregu-
lated genes upon cohesin loss are com-
parable. It also remains possible that co-
hesin-mediated long-range looped
interactions contribute directly to gene
repression. A challenge in the field will
be to assess the direct contribution of
cohesins to the formation of DNase I
hypersensitive sites and transcription fac-
tor access.
What attracts cohesins and their
loading factors to active genes, and how
are they retained on mitotic chromatin?
Cohesins interact with DNA-binding
transcription factors, mediator, and chro-
matin-remodeling complexes (Dorsett
and Merkenschlager, 2013). However,
most examined chromatin-binding pro-
teins are lost from chromatin during
mitosis. Therefore, defining the mecha-
nism bywhich cohesins bindmitotic chro-
matin is of high priority.
Another critical unresolved question is
whether mitotic retention of cohesin
does indeed serve a cellular memory
function. Conventional loss-of-function
experiments are unsuitable to address
this question given the pleiotropic func-
tions of cohesins. Previously, mitosis-
specific destruction of a transcription
factor has been accomplished by engi-
neering it such that it can be degraded
via the anaphase promoting complex
(APC) (Kadauke et al., 2012). The APCCell 15normally triggers a pathway that culmi-
nates in the centromeric removal of
cohesin during anaphase to allow sepa-
ration of sister chromatids. From the Yan
et al. study, it appears that this process
spares enhancer- or chromatid-arm-
bound cohesins (although it is unclear
whether the molecular organization of
the cohesin complex remains the same
in mitosis). Therefore, this strategy might
be useful to also remove enhancer-
associated cohesin during mitosis thus
enabling examination of the conse-
quences on gene expression and cellular
memory.
If cohesins at enhancers turn out to
convey mitotic memory, this would
provide a broad mechanism of mitotic
bookmarking. Certainly, it would not be
the only one. For example, cohesins
have not been identified as partners of
transcription factor GATA1 or its cofac-
tors, but mitotically stable GATA1 is
required for the timely reactivation of
postmitotic gene expression (Kadauke
et al., 2012). The Yan at al. report also
touches on S phase showing chromatin
binding of cohesins as well as some
DNA-binding proteins in S phase cell
populations. However, the fate of most
DNA-binding proteins during DNA repli-
cation has not been examined in detail,
precluding conclusions regarding a
requirement for a specific memory mech-
anism during this phase of the cell cycle.
The present findings impact on the
interpretation of genetic alterations of
cohesins and cohesion-loading factors
including those that underlie develop-
mental disorders such as Cornelia de
Lange syndrome and Roberts syndrome.
The challenge ahead will be to untangle
the cohesin pathologies with regard
to their impact on chromosome segre-
gation, DNA repair, and enhancer func-
tion, the latter including transcription
factor loading and long-range chromatin
interactions. The work from the Yan
et al. report adds impaired transcrip-
tional memory to the possibilities to be
considered.
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Understanding the ontogeny of distinct hematopoietic cell types remains a challenge. In this issue,
Schraml et al. contribute to unraveling the complexity of a central component of the mononuclear
phagocyte system by using a new in vivo approach to trace the progeny of common dendritic cell
precursors.‘‘It was exciting when dendritic cells ap-
peared first as novel cells, and it remains
exciting that these cells represent a
novel force in medicine’’ (Steinman,
2012). After the original discovery of
dendritic cells (DCs) by Steinman and
Cohn in 1973, mainstream immunolo-
gists took several decades to fully recog-
nize the pivotal role of these myeloid leu-
kocytes. Today, DCs are well established
as central instigators and regulators of
both innate and adaptive immune
responses and have been used in pre-
clinical and clinical settings to treat
inflammatory diseases, alloimmunity, in-
fections, and cancer. Consequently, in
2011, Ralph Steinman was awarded the
Nobel Prize in Physiology or Medicine
for his discovery.
Strategically positioned in the skin, on
mucosal surfaces, and in other tissues
throughout the body, DCs are effective
sensors and phagocytic collectors of anti-genic material from a variety of sources,
including pathogens and cancer cells;
when DCs acquire antigen in a peripheral
tissue, they migrate to lymphoid organs,
where they function as potent activators
of antigen-specific lymphocytes (Merad
et al., 2013). However, not all DCs are
created equal; a growing number of sub-
sets have been identified in both mice
and humans that express distinct pheno-
typic markers and play specialized roles
in the immune system. A better under-
standing of the origins of these subsets
and the rules that determine their produc-
tion and function could not only generate
better insights in the intricacies of immune
regulation but may also reveal novel
avenues for therapeutic or prophylactic
immune modulation and vaccine devel-
opment; however, progress in this area
has been slow due to inherent limita-
tions in hitherto available biological tools
(Figure 1A).In this issue ofCell, Schraml et al. (2013)
report an in vivo lineage-tracing approach
that refines our understanding of DC sub-
set ontogeny. The authors employed an
in vivo genetic tagging strategy that spe-
cifically marks common DC precursors
and all of their progeny by constitutive
expression of enhanced yellow fluores-
cent protein (EYFP). This strategy not
only confirms and solidifies previously
held notions of the origin of several
DC subsets but also yields unexpected
discoveries, namely the identification
of common DC precursor-derived leu-
kocytes in the small intestine and kid-
ney. These DC subsets were previously
believed to be of monocyte origin
because earlier lineage-tracing studies
were unable to pinpoint their origin due
to technical limitations.
Historically, new cell types have been
defined based on morphology, surface
phenotype, and/or function, and it has
